CSL Competitors and Similar CompaniesClear all
CSL's competitors and similar companies include Walvax Biotechnology, Biohaven Pharmaceutical and Serum Institute of India.
 Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. |  Biohaven Pharmaceutical Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system. | |||
Founding Date | Founding Date 1916 | Founding Date 2001 | Founding Date 2014 | Founding Date 1966 |
Type | Type Public | Type Public | Type Subsidiary | Type Subsidiary |
Tags | ||||
Locations | Locations Parkville, AU HQ King Of Prussia, US | Locations Kunming, CN HQ | Locations New Haven, US HQ | Locations Pune, IN HQ Mumbai, IN Pune, IN |
Employees | Employees 32,6982% increase | Employees 2,388 | Employees 4692% decrease | Employees 4,8671% increase |
Valuation ($) | Valuation ($) 95.1 b | Valuation ($) 3.4 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $14.7b (FY, 2024) | Revenue (est.) ¥4.1b (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $6.2b (FY, 2024) | Cost of goods ¥597.6m (FY, 2023) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $8.6b (FY, 2024) | Gross profit ¥3.5b (FY, 2023) | Gross profit N/A | Gross profit N/A |
Net income | Net income $2.7b (FY, 2024) | Net income ¥511.3m (FY, 2023) | Net income N/A | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 72.8m | Total funding raised $ 80m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Walvax Biotechnology
HQ
Kunming, CN
Employees
2,388
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
View companyBiohaven Pharmaceutical
HQ
New Haven, US
Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.
View company